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Abstract
Background: The initial step of metastasis in carcinomas, often referred to as the epithelialmesenchymal transition (EMT), occurs via the loss of adherens junctions (e.g. cadherins) by the
tumor embolus. This leads to a subsequent loss of cell polarity and cellular differentiation and
organization, enabling cells of the embolus to become motile and invasive. However highly
malignant inflammatory breast cancer (IBC) over-expresses E-cadherin. The human xenograft
model of IBC (MARY-X), like IBC, displays the signature phenotype of an exaggerated degree of
lymphovascular invasion (LVI) in situ by tumor emboli. An intact E-cadherin/α, β-catenin axis
mediates the tight, compact clump of cells found both in vitro and in vivo as spheroids and tumor
emboli, respectively.
Methods: Using electron microscopy and focused ion beam milling to acquire in situ sections, we
performed ultrastructural analysis of both an IBC and non-IBC, E-cadherin positive cell line to
determine if retention of this adhesion molecule contributed to cellular organization.
Results: Here we report through ultrastructural analysis that IBC exhibits a high degree of cellular
organization with polar elements such as apical/lateral positioning of E-cadherin, apical surface
microvilli, and tortuous lumen-like (canalis) structures. In contrast, agarose-induced spheroids of
MCF-7, a weakly invasive E-cadherin positive breast carcinoma cell line, do not exhibit
ultrastructural polar features.
Conclusions: This study has determined that the highly metastatic IBC with an exaggerated
malignant phenotype challenges conventional wisdom in that instead of displaying a loss of cellular
organization, IBC acquires a highly structured architecture.
These findings suggest that the metastatic efficiency might be linked to the formation and
maintenance of these architectural features. The comparative architectural features of both the
spheroid and embolus of MARY-X provide an in vitro model with tractable in vivo applications.

Background
Normal epithelial tissue has a distinct architecture. The
organization and maintenance of this tissue architecture is

mediated by cell-cell adhesion junctions [1]. The most
notable of the adhesion junctions is the adherens junction
(AJ). The AJs are critical for the formation of a polarized
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epithelial sheet composed of two structurally distinguishable surfaces, namely the apical and basal [1-3]. The transmembrane protein E-cadherin forms AJs and binds to the
family of catenins (e.g. α-catenin, β-catenin, p120) on the
cytoplasmic side of the plasma membrane [4,5]. This
intact E-cadherin α/β-catenin axis regulates cytoskeleton
dynamics [2]. Nuclear translocation of β-catenin upon
cleavage of a formerly intact axis alters gene transcription
[4]. Positioned directly adjacent to the AJ is the tight junction (TJ). In glandular epithelium the TJs are lumenallylocated (apical face) in relationship to the AJs. These junctions are predominantly composed of claudin proteins
and are responsible for regulating ion permeability [1,6].
More basally-located are the desmosomes (DMs) and
these junctions provide resistance to shear stress of epithelial tissue and are composed of desmosomal cadherins
(desmocollins, desmogleins) [1,7]. The desmosomal cadherins are linked to intermediate filaments of plaque proteins (desmoplakin, plakoglobin and plakophillin) in the
cytoplasm [7]. The hallmark structure of a polarized epithelial sheet is the tripartite complex composed of a TJ, AJ
and DM. This structural complex is observed in electron
micrographs and is located at the apex (apical/lateral) of
adjacent cells [2,8]. In normal epithelial tissue polarity
results in an asymmetric distribution of protein receptors/
transporters, signaling complexes, ion channels and lipids
between two surfaces, the apical and basolateral [1]. It is
the maintenance of the architectural integrity and function of the two surfaces which traditionally distinguish
normal from aberrant cells.
Most cancers arise from epithelial cells and the initial step
in metastatic progression is reduced intercellular adhesion
[9,10]. This is primarily associated with the loss of E-cadherin function with subsequent loss of cell polarity, epithelial differentiation and organization [11-13]. With the
loss of positional cues the cancer cells are relieved of contact inhibition of growth and become more motile and
invasive [10]. A loss of E-cadherin results in a loss in all
epithelial features and is sufficient to accelerate the adenoma-to-carcinoma transition in mouse tumor models,
indicating that loss of E-cadherin may be a rate-limiting
step in tumor progression [14].
Reduced expression of E-cadherin with diminution of
cell-cell junctions is generally accepted as a malignancy
indicator [15]. Paradoxically, human inflammatory breast
cancer (IBC), a highly metastatic carcinoma, overexpresses E-cadherin [16-18]. The human xenograft
model of IBC (MARY-X), like IBC, displays the signature
phenotype of an exaggerated degree of lymphovascular
invasion (LVI) in situ by tumor emboli [19]. MARY-X also
exhibits a 10 - 20 fold over-expression of an intact E-cadherin/α, β- catenin axis [19]. This over-expressed highly
functional adhesion molecule mediates the tight, com-
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pact clump of cells found both in vitro as spheroids and in
vivo as tumor emboli [20,21]. Compaction due to E-cadherin confers resistance to apoptosis [22]. In MARY-X, disruption of the intact axis by Ca++ depletion, E-cadherin
antibody, glycan modification of MUC1 and trypsin proteolysis results in the total dissolution of the in vitro spheroids followed by apoptosis, suggesting that overexpressed E-cadherin/α, β-catenin axis plays an important
role in the survival of highly metastatic IBC [20-22].
In this study, using the human xenograft model of IBC
(MARY-X) we show that malignant IBC displays architectural features or a gain in cellular organization that is not
typically found in aggressive carcinomas. This architecture, found both in vitro and in vivo, exhibits intact tight
junctions, adherens junctions and microvilli coating of
the apical surface of lumen-like structures (canalis), which
are evenly distributed throughout the MARY-X spheroid
and tumor cell embolus. This 3D in vitro model that truly
mimics the in vivo physiological/pathological conditions
provides tractable information concerning structural
architecture and metastatic behavior of the in vivo tumor
cell embolus.

Methods
MARY-X xenograft and in vitro spheroids
MARY-X was established from a patient with inflammatory breast cancer (IBC) [19]. In vivo, MARY-X recapitulates the human IBC phenotype of extensive
lymphovascular invasion of the tumor cell emboli. The
IBC spheroids are a cellular derivative (i.e. primary cell
line) of MARY-X primary tumor explants. Upon mincing
the tumor cells are released into the media as sheets of
cells and single cells. The tumor cells form tight, compact
clumps or aggregates of cells termed "MARY-X spheroids".
These spheroids can be further purified or partitioned
from the cellular debris by employing cell strainers of varying pore sizes (e.g. 40, 70 and 100 μm; BD Biosciences)
[21]. The resultant preparation is 100% human IBC cells
(termed MARY-X spheroids) which can be maintained in
culture for periods up to three months.

The MARY-X spheroids when injected into severe-combined immune deficient (SCID) mice, form complex primary tumors (and distant lung metastases) where the
tumor cell emboli are found nestled within the murine
lymphatics and blood vessels (i.e. lymphovascular invasion) [19]. The tumor is composed of a 30% murine component (surrounding stroma, lymphatic vessels and
blood vessels) and 70% human inflammatory breast cancer cell component (tumor cell emboli) [19].
MCF-7 (American Type Culture Collection, Rockville,
MD) spheroids were established by plating MCF-7 cells
on a 1% agarose-coated tissue culture plate.
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All cells were maintained in minimal essential medium
(MEM) containing 10% fetal bovine serum and antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin) at
37°C in an air-5% CO2 atmosphere at constant humidity.
All experiments were performed in compliance with the
Memorial Sloan-Kettering Cancer Center Animal Care
and Use Program (Protocol Number 06-04-006).
In vitro Dissolution Studies
The MARY-X spheroids underwent full dissolution by
either calcium depletion or the adhesion-blocking E-cadherin antibody (Invitrogen, clone HECD-1) as previously
reported [22]. Cytospin preparations were obtained for
dissolute spheroids.
Transmission Electron Microscopy
MARY-X spheroids, tumor emboli and MCF-7 agaroseinduced spheroids were fixed for 2-24 hours at 4°C in 3%
Glutaraldehyde/0.1 M sodium cacodylate buffer (pH 7.2)
and post-fixed for 45 min in buffered 1% osmium tetroxide. The samples were dehydrated in a series of ethanol
solutions followed by a propylene oxide rinse and infiltrated with Embed 812 resin. Thin sections (120 nm) were
cut with a diamond knife on a LKB microtome and collected on nickel grids (EMS: G300H-Ni). Sections were
stained in 4% uranyl acetate for 1-2 hours followed by
0.6% lead citrate for 20 minutes. Sections were viewed on
a Zeiss EM902 transmission electron microscope and
images were captured digitally using a Mega View III CCD
camera with a pixel resolution of 1.3 Megapixels. Analysis
of spheroid preparations was performed on spheroid pellets (5,000 - 10,000 spheroids/pellet). TEM viewing was
performed on 20 - 30 randomly chosen fields of multiple
spheroid pellet and tumor emboli preparations.
Scanning Electron Microscopy
MARY-X spheroids, tumor emboli and MCF-7 agaroseinduced spheroids were fixed and post-fixed as described
in the TEM protocol above, dehydrated in a series of ethanol solutions and dried using a critical point dryer
(Balzer CPD-030). The dried samples were coated with a
2 -3 nanometers of gold using a Denton Desk II sputter
coater. Observations were made using a scanning electron
microscope (Supra 55 VP or Quanta 200 3D). Spheroid
pellet preparations (5,000 - 10,000 spheroids/pellet) are
mounted (scattered) onto pins and sputter-coated as
described. Observations were performed on 10 - 20 individual spheroids of multiple preparations.
Scanning Electron Microscopy/Focused Ion Beam Milling
Milling of the specimens was performed using a Quanta
200 3D dual beam SEM-FIB. In situ sections (i.e. milling)
were achieved with an initial blunt section at a current of
20 nA, followed by decreasing currents (20 - 3nA) for pol-
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ished sections. Images were captured at a 1 Megapixel resolution.
Immunofluorescence
The antibodies used for immunofluorescence included Ecadherin (BD Transduction labs; catalogue #610181) and
β-catenin (Sigma; catalogue #C 2206). The monoclonal
antibody for E-cadherin recognized the intracellular
domain. Immunofluorescence was observed using an
upright Leica TCS SP2 AOBS 1- and 2-photon laser scanning confocal microscope.

Results and Discussion
Polar Architectural Features of MARY-X
Architectural integrity or structural organization is known
to be disrupted following loss of cell-cell adhesion during
pathogenesis (i.e. malignant progression) of epithelial
tumors [11,13]. However highly malignant inflammatory
breast cancer (IBC) over-expresses E-cadherin. The human
xenograft model of IBC (MARY-X), like IBC, displays the
signature phenotype of an exaggerated degree of lymphovascular invasion (LVI) in situ by tumor emboli and
also over-expresses E-cadherin. This over-expression of Ecadherin by MARY-X is maintained throughout the metastatic progression (Figure 1).

Transmission electron microscopic (TEM) analysis was
performed to investigate the paradox of E-cadherin overexpression in the MARY-X spheroid and whether it
extended beyond the molecular function (e.g. compaction and resistance to induction of apoptosis, as previously reported) and contributed to cellular organization.
Apparent upon ultrastructural analysis were several
lumen-like structures (canalis) formed by adjoining cells
located in the inner regions of the MARY-X spheroid (Figure 2A and 2B). Consistent with an apical surface of polar
epithelial cells, the surface of the canalis was coated with
microvilli (Figure 2A and 2B). Further electron microscopic evaluation under higher magnification of the apex
of adjacent cells revealed apical/lateral positioning of AJs
(Figure 2A and 2B; right panels). Also present, was the
more lumenally-located TJ (referred to also as zonula
occludens) and the basally-localized DM (Figure 2A and
2B; right panels). This tripartite complex, TJ, AJ and DM,
of the MARY-X spheroid authenticates polarity with the
distinct feature of establishing two separate plasma membrane domains, the apical and basolateral surface. These
architectural features were also observed in the TEM analysis of the MARY-X tumor cell emboli (data not shown).
Initial electron microscopic analysis therefore suggests
that the over-expression of the intact E-cadherin/α, β-catenin axis extends beyond molecular function and displays
a first order level of structural organization uncommon in
a carcinoma with a malignant phenotype. To the best of
our knowledge such structural features have not been pre-
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Figure 1 expression of MARY-X:
E-cadherin
E-cadherin expression of MARY-X: The MARY-X spheroids (left panel), tumor emboli of a primary tumor (middle panel)
and emboli of pulmonary metastases (right panel) display strong membrane-located E-cadherin staining (40× magnification).
Nuclei of all sections were stained with 4',6-diamidino-2-phenlylindole (DAPI).

Figure
TEM
of MARY-X
2
spheroids:
TEM of MARY-X spheroids: (A; left panel, B; left panel, arrows) Canalis with extensive microvilli (MV) are found on the
interior of several adjoining cells (N; nucleus). (A, B; right panels, note that right panel of B correlates with boxed arrow on the
left panel) Found at the apex (apical/lateral) of adjoining cells within the canalis are tight junctions, adherens junctions and
desmosomes (TJ; arrow, AJ; arrow and DM; arrow).
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viously reported in spontaneously forming in vitro spheroids.
The canalis found upon ultrastructural analysis of MARYX, presented compelling evidence for the existence of a
hierarchy of structural architecture within the multicellular spheroid. Given the two-dimensional (2D) nature of
the electron micrographs, the images of canalis could represent a series of blind diverticulum or cavities within the
spheroid. Therefore to further investigate, tomography of
individual MARY-X spheroids (70 μm-200 μm in diameter), was analyzed using SEM (Figure 3). The outer surface
of the spheroid is covered extensively with short microvilli. Clusters of dimple-like structures can be seen
throughout the spheroid surface (Figure 3; arrow and Figure 4A and 4B; arrow heads). When explored further
under higher magnification, these dimple-like structures
(Figure 3; inset and Figure 4C-F; red and black arrows)
were found to be orifices covered with long, dense, fibrous
microvilli (Figure 4D and 4F). While maintaining the
three-dimensional (3D) context, the spheroid was then
sectioned using the integrated scanning electron microscopy/focused ion beam (SEM/FIB) milling technology.
Using the FIB, sections (i.e. milling) were produced in situ
of the spheroid (Figure 5). The canalis were found to originate as orifices on the surface and extend deep within the
interior of the spheroid (Figure 5C-D). The canalis appear
to be tortuous and highly bifurcating (Figure 5B).
Although not as apparent as was seen on the spheroid surface and orifice, the interior canalis do retain a coating of
microvilli (Figure 5C and 5D). Compatible with the TEM
findings, the tortuous canalis are formed by the polar
assembly of the multicellular spheroid and represent a
second order level of structural organization, confirming
an architectural hierarchy within the malignant carcinoma, IBC.
E-cadherin contributes to the organized assembly of IBC,
however, to determine whether E-cadherin-expression
alone or a combined innate predisposition of IBC, contributed to a gain in cellular organization, the ultrastructure of the non-IBC breast carcinoma, MCF-7, was
examined. MCF-7 is a weakly invasive non-IBC cell line
that like MARY-X expresses a significant level of E-cadherin as reported earlier [21]. The MCF-7 cell line can be
induced to form spheroids in culture when attachment as
a monolayer is prohibited (i.e. 1% agarose-coated plates).
This method of inducing 3-dimensional multicellular
spheroids is commonly used to test therapeutic efficacy
because these artificial multicellular spheroids more
closely resemble the in vivo metastasis (i.e. compact
clump of cells) [23-26]. When examined by TEM these Ecadherin-expressing spheroids did not display polar elements as seen in MARY-X spheroids (Figure 6). Adjoining
cells did not form tripartite complexes but rather continu-
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ous junctions predominantly composed of tight junctions
(TJs) and/or desmosomes (DM) and hemi-desmosomes
(hDM) (Figure 6B; left panel) at what would constitute
the apex of the apical/lateral surface. Internal regions of
the MCF-7 spheroid revealed similar findings where adjacent cells formed junctions predominantly of DMs and
hDMs (Figure 6A and 6B; right panels). Most significantly,
MCF-7 ultrastructure did not display internal canalis (Figure 6A and 6B; right panels). The overall surface of the
MCF-7 spheroid exhibited discontinuous spheroid surface microvilli (Figure 6A; left panel, arrows). A previous
ultrastructural study of agarose-induced MCF-7 spheroids
reported similar results with cell-cell contacts predominantly forming tight junctions and desmosomes with no
tripartite complex [27]. Scanning electron microscopic
(SEM) and focused ion beam (FIB) milling analysis was
performed on the agarose-induced MCF-7 spheroids and
further confirmed the absence of any level of cellular
organization i.e. surface orifices, lumen-like structures
(Figure 6C and 6D). The difference in the expression level
of E-cadherin and the fact that the MCF-7 cell line does
not spontaneously form spheroids in vitro may partially
explain the absence of cellular organization of the agarose-induced MCF-7 spheroids.
It is known that cleaving the intact E-cadherin/α, β-catenin axis induces a cascade of signaling events culminating in β-catenin nuclear translocation and alteration of
gene transcription [5]. To assess the consequences of disruption of the intact axis in the MARY-X spheroids, dissolution upon Ca++ depletion was performed. At time points

Figure
SEM
of MARY-X
3
Spheroid:
SEM of MARY-X Spheroid: SEM analysis reveals multiple
"dimple-like" features (e.g. arrow) amidst short microvilli on
the surface of the spheroid. Magnification (inset) shows a
canal orifice.
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Figure
SEM
of MARY-X
4
Spheroid and lumen orifices:
SEM of MARY-X Spheroid and lumen orifices: (A and B) Multiple clusters of canalis orifices seen as "dimples" on the surface of the spheroid (black arrowheads and black and red arrows; magnified in C & E). (C and E) Short microvilli coat the surface of the spheroid. (D and F) Magnification of the "dimples" i.e. lumen orifices shows dense, long microvilli lining the exterior
portion.
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Figure 5milling of MARY-X spheroid:
SEM/FIB
SEM/FIB milling of MARY-X spheroid: (A and B) FIB milling of the MARY-X spheroid shows a network of canalis evenly
distributed through out the spheroid. (C and D) Microvilli are seen within the canalis (arrows).

3, 6, 8, 10, 12, and 24 hours, aliquots of the dissolute
spheroids were removed. Cytospin preparations of the
aliquots were double-labeled with a β-catenin antibody
and an E-cadherin antibody specific to the cytoplasmic
domain of this molecule. At 3 hours of dissolution both
β-catenin and E-cadherin co-localize at the plasma membrane, representing an intact axis (Figure 7; 3 HR). Surprisingly, by 6 hours, while β-catenin continued to be
positioned at the plasma membrane, E-cadherin was
translocated to the nucleus (Figure 7; 6 HR). This appearance was maintained for up to 24 hours (Figure 7; 3 HR
24 HR). From 10 to 24 hours, plasma membrane degen-

eration was observed. Interestingly, the time scale of Ecadherin nuclear translocation overlapped with the induction of apoptosis in dissolute spheroids from previously
reported data, which was also achieved in approximately
6 hours [22]. The nuclear translocation of the cytoplasmic
domain of E-cadherin upon dissolution of the formerly
intact MARY-X spheroids presents a novel function of Ecadherin. E-cadherin translocation to the nucleus was also
observed when disruption of the intact axis was achieved
using an E-cadherin antibody (clone HECD) specific for
the extracellular domain of the transmembrane protein
(data not shown), proving that translocation is not due to

Page 7 of 12
(page number not for citation purposes)

BMC Cancer 2009, 9:462

http://www.biomedcentral.com/1471-2407/9/462

Figure
TEM
and6 SEM of MCF-7 spheroids:
TEM and SEM of MCF-7 spheroids: (A, B) TEM analysis reveals MCF-7 spheroids with discontinuous microvilli (arrows) on
the surface of the spheroid. (A, B; right panels) Adjoining cells of MCF-7 spheroids form both desmosomes and hemidesmosomes (DM, arrow & hDM, arrow) but no tripartite complex. (C) SEM analysis of agarose-induced MCF-7 spheroids showed
discontinuous surface microvilli and no surface orifices (inset). (D) In situ sections (box) revealed a smooth cellular cross section with no lumen-like structures.
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Figure 7translocation of E-cadherin upon disruption of intact axis:
Nuclear
Nuclear translocation of E-cadherin upon disruption of intact axis: (Red channel; E-cadherin 1° antibody conjugated
to 568 nm fluorophore, Green channel; β-catenin 1° antibody conjugated to a 488 nm fluorophore). (3 HR) Co-localization of
E-cadherin and β-catenin at the plasma membrane is seen. (6 HR 24 HR) Prolonged disruption results in E-cadherin nuclear
translocation. (10 HR 24 HR) Membrane degeneration is observed.

a calcium-dependent signaling mechanism. Nuclear
translocation of E-cadherin within MCF-7 cells has also
been reported in a previous study with a possible role in
suppression of drug-induced apoptosis [28]. Albeit the
level of E-cadherin is lower in MCF-7 than in MARY-X
spheroids, we have found apoptotic response and nuclear
translocation of the cytoplasmic domain of E-cadherin
upon disruption of molecular function of E-cadherin to
be almost equal [22,28]. However, ultrastructural analysis
of MCF-7 agarose-induced spheroids was found to be very
different. Pursuit of the molecular function of E-cadherin
once in the nucleus of MARY-X, although unexpected and
interesting, is beyond the scope of this paper.
The information that malignant IBC retains structural
integrity gives exciting insight into the possibility that
metastatic efficiency in some carcinomas is independent
of "loss of function" i.e. loss of cellular differentiation
accompanied by higher mobility and invasiveness resulting from reduced intercellular adhesion [11,13]. According to traditional definition, architectural integrity is
disrupted during pathogenesis of epithelial tumors and
pathological assessment is based predominantly on
microscopic evaluation of (loss of) epithelial cell features

[11,29]. Histological patterns, such as the loss of E-cadherin expression in carcinomas is the most widely
accepted malignant and prognostic indicator in diagnosis
of the disease [15]. However, ultrastructural features cannot be seen in these typical evaluations and "gain in function" or structural organization has not been explored
with respect to possible clinical outcomes.
The Polar Architectural Features of the MARY-X In Vitro
Spheroid Mimic the In Vivo Metastasis
We next asked if the structural features, specifically the
canalis, of the in vitro MARY-X spheroid recapitulated
those of the in vivo MARY-X tumor cell emboli to further
confirm the link between architectural features and metastatic efficiency. MARY-X form tight, compact aggregates
of cells which manifest as spontaneously-formed spheroids in vitro and lymphovascular emboli in vivo (Figure
8A and 8B; top and middle panels). These human IBC
cells (MARY-X spheroids) when injected into immune
compromised mice will form complex primary tumors
where the lymphovascular emboli are nestled within the
murine surrounding stroma (Figure 8B; top panel). Upon
malignant progression, pulmonary metastases will form
within the pulmonary vessel network as simple (Figure
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Spontaneously
Figure 8
formed in vitro MARY-X spheroids mimic the in vivo metastasis:
Spontaneously formed in vitro MARY-X spheroids mimic the in vivo metastasis: (A; top and middle panels) In vitro,
MARY-X forms a compact 3D multicellular structure in suspension, ranging in size from as small as 10 μm to as large as 400
μm in diameter (10× and 40× magnification, respectively). (A; bottom panel) FIB milling of the MARY-X spheroid displays
extensive canalis structures throughout the MARY-X spheroid. Extensive surface microvilli (inset, arrow) adjacent to a canal as
displayed in the FIB section (B; top and middle panels) A cross-section of a MARY-X primary tumor and murine lung metastases shows compact, multicellular MARY-X lymphovascular emboli (E) (H & E stained, 40× and 20× magnification). The pulmonary metastasis may exist as a simple single distinct lymphovascular embolus (middle panel; inset, E) or a more complex
metastasis where the lymphovascular emboli are nestled within the murine surrounding stroma (middle panel, E). (B; bottom
panel) Surface SEM of a cross-section of MARY-X emboli displays canalis with microvilli (inset).
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8B; middle panel, inset) or complex pulmonary metastases (Figure 8B; middle panel) comparable to the primary tumor (Figure 8B; top panel). Surface SEM analysis
of a cross-section of MARY-X tumor emboli, like the in
vitro MARY-X spheroid, reveals tortuous and highly bifurcating canalis (Figure 8A and 8B; lower panels). At higher
magnification, the interior of the canalis of the tumor
embolus is coated with microvilli (Figure 8B; lower panel,
inset). Like the spontaneously formed in vitro MARY-X
spheroid, the in vivo MARY-X tumor cell embolus displays
unique architectural features. These data show that structural integrity of the malignant IBC is maintained
throughout metastatic progression and most importantly,
this makes MARY-X an in vitro model with tractable in vivo
applications.

Conclusions
A limitation in our understanding of epithelial tissue and
tumors that are derived from them is that most insight
into the formation, maintenance, function and pathology
of epithelial tissue has depended on the analysis of traditional 2D cell tissue culture. This approach has been particularly useful in cancer research to determine drug
response and toxicity in carcinomas. However, the results
of a number of studies comparing the response of cells to
drugs are often different when cells are cultured in 2D due
to the failure to recapitulate the native 3D in vivo state
[27,30]. In addition, 2D cultures differ significantly in
morphology, signaling and differentiation. In vitro 3D
models (e.g. explants and traditional 2D cultures in
matrix scaffolds) have been developed as an intermediate
between the 2D cultures and animal models to better
understand in vivo 3D physiological conditions/environment [29,31,32]. These in vitro 3D models offer expeditious assessment of drug response and toxicity and more
closely resemble in vivo morphology and intracellular signaling [30]. Studies using 3D models appear to better correlate with drug response found in vivo [33]. However
these models show significant variability of in vivo conditions and offer only short term in vitro conditions [30].
The most significant difficulty is the inability of these in
vitro 3D models to fully mimic the defined in vivo 3D orientation, of either normal (i.e. polarity; distinct structural
architecture) or aberrant (loss of structural integrity) epithelial cells, that dictates intracellular, intercellular and
cell extracellular matrix (ECM) signaling [33].
Therefore, presently, the in vitro study of metastatic progression using 2D cultures has limited bearing on the in
vivo situation. Even when the 3D architecture is recreated
in the in vitro model or artificial soft agar scaffolds, the
multicellular spheroids are dissimilar to micrometastases
[30,33]. However, the MARY-X model is similar in that it
grows as spontaneous, tight multicellular spheroids in
vitro and as lymphovascular emboli in vivo, both display-

http://www.biomedcentral.com/1471-2407/9/462

ing the same highly organized structural architecture. This
true recapitulation provides us with a 3D in vitro model
with tractable in vivo applications. The MARY-X model
will allow us to manipulate these spheroids in culture and
identify key gene products that convert IBC architecture to
a more indolent carcinoma and determine if this affects
metastatic behavior in vivo. Our study offers an alternative
perspective as to what constitutes an aggressive carcinoma
with a poor clinical outcome. Understanding carcinomas
such as IBC that have a "gain in function" i.e. cellular
organization could offer new strategies and approaches in
treatment.
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